August 21, 2018
Fitch Even partner Kendrew H. Colton is quoted in an article published in the August 19, 2018 issue of Chemical & Engineering News, a weekly publication of the American Chemical Society.
The article, titled "Firms Feud Over Niagen, A Purported Age-Fighting Molecule," discusses the ongoing patent dispute between ChromaDex and Elysium Health over rights to nicotinamide riboside or NR, a molecule with promising vitamin-like qualities.
Ken has been practicing intellectual property law for over 30 years. His primary practice focus is counseling clients on a wide range of IP matters involving established and emerging chemical and biochemical technologies. Ken has been a member of the Chemical & Engineering News Advisory Board since 2012.
- IP Alert | USPTO Releases Latest Guidance for Evaluating Subject Matter Eligibility Under 35 U.S.C. § 101January 11, 2019 Read more
- IP Alert | USPTO Releases Guidance for Examining Computer-Implemented Functional Claim Limitations for Compliance with 35 U.S.C. § 112January 11, 2019 Read more